Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × glucopyranosyl lipid-A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 1 Melanoma 1 Colorectal Cancer Metastatic 1 Carcinoma, Merkel Cell 1

Interventions

Bevacizumab 19 Capecitabine 15 Oxaliplatin 11 Irinotecan 11 Cetuximab 11 Fluorouracil 10 Leucovorin 8 aflibercept 7 Panitumumab 6 trifluridine tipiracil drug combination 4 Nivolumab 4 sintilimab 3 regorafenib 3 Ipilimumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Folfox protocol 2 Drug Therapy 2 tremelimumab 1 spartalizumab 1 raltitrexed 1 pembrolizumab 1 monoclonal antibody YYB-101 1 masitinib 1 irinotecan sucrosofate 1 glucopyranosyl lipid-A 1 folfirinox 1 durvalumab 1 camrelizumab 1 balstilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03982121 2020-02-17

ISILI

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡